Latest filing published 20 Jul 2018 for Angiodynamics INC.
Insider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +10.1%Entry US$14.27 · Close at T+365 US$15.71
- -4.4%Entry US$15.39 · Close at T+365 US$14.71
- -4.6%Entry US$15.66 · Close at T+365 US$14.94
- +1.8%Entry US$16.60 · Close at T+365 US$16.90
- +33.7%Entry US$11.95 · Close at T+365 US$15.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Steve LaPorte: trading record in brief
Steve LaPorte is a declared insider at 2 companies; the most frequent names are Angiodynamics Inc and Rita Medical Systems Inc. We count 27 filings; the first trade dates from 3 July 2006 and the latest from 18 July 2018.
No open-market sale appears; the market trades are 10 purchases worth €85k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 14 share grants and 3 option exercises.
Half of the purchases are above €7,457 and half below. Ninety days after publication, 8 purchases show a median change of +1.1%, with the price up in 50% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 20 July 2018, reports a share grant in Angiodynamics Inc. The last insider purchase was made public on 20 October 2010, 5,864 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Steve LaPorte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,307 shares0Common StockSEC:0001140361-18-033085:0
- 7,976 shares0Common StockSEC:0001140361-17-029112:0
- 14,000 shares@ US$15.7528.4% of flowCommon StockSEC:0001140361-17-002000:0
- 14,000 shares@ US$17.9232.3% of flowCommon StockSEC:0001140361-17-002000:1
- 5,063 shares0Common StockSEC:0001140361-16-073907:0
- 12,000 shares@ US$13.2919.7% of flowCommon StockSEC:0001140361-16-072638:0
- 10,005 shares@ US$15.9419.7% of flowCommon StockSEC:0001140361-16-072638:1
- 5,266 shares0Common StockSEC:0001140361-15-030134:0
- 6,193 shares0Common StockSEC:0001140361-14-033021:0
- 1,616 shares0Common StockSEC:0001140361-13-039525:0
- 3,000 shares0Common StockSEC:0001140361-13-031273:0
- 2,850 shares0Common StockSEC:0001140361-12-036064:0
- 500 shares@ US$14.29Common StockSEC:0001275187-10-000026:0Canonical exit: 17 Jan 2011 (T+90)
- 500 shares@ US$14.69Common StockSEC:0001275187-10-000005:0Canonical exit: 18 Oct 2010 (T+90)
- 500 shares@ US$15.52Common StockSEC:0000914121-10-001096:0Canonical exit: 6 Jul 2010 (T+90)
- 500 shares@ US$16.35Common StockSEC:0001275187-10-000002:0Canonical exit: 13 May 2010 (T+90)
- 2,000 shares@ US$11.42Common StockSEC:0001275187-09-000019:0Canonical exit: 20 Oct 2009 (T+90)
- 1,000 shares@ US$12.00Common StockSEC:0001275187-09-000001:0Canonical exit: 9 Apr 2009 (T+90)
- 1,000 shares@ US$15.92Common StockSEC:0001275187-08-000009:0Canonical exit: 3 Nov 2008 (T+90)
- 1,300 shares@ US$15.13Common StockSEC:0001275187-08-000008:0Canonical exit: 13 Aug 2008 (T+90)
20 of 20 declarations
